Glenn Tilton - AbbVie Insider

AbbVie Inc -- USA Stock  

USD 103.81  0.55  0.53%

Independent Director

Mr. Glenn Fletcher Tilton is the Lead Independent Director of the Company. He was chairman of the Midwest for JPMorgan Chase Co. from 2011 until his retirement in 2014. From October 2010 to December 2012, Mr. Tilton also served as the nonexecutive chairman of the board of United Continental Holdings, Inc. From September 2002 to October 2010, he served as chairman, president and chief executive officer of UAL Corporationrationration, and chairman and chief executive officer of United Air Lines, Inc., its wholly owned subsidiary. Prior to becoming the vice chairman of Chevron Texaco following the merger of Texaco Inc. and Chevron Corporationration, Mr. Tilton enjoyed a 30year multidisciplinary career with Texaco Inc., culminating in his election as chairman and chief executive officer. Mr. Tilton is also a director of Abbott Laboratories and Phillips 66. Mr. Tilton also served on the board of directors of Lincoln National Corporationrationration from 2002 to 2007, of TXU Corporationrationration from 2005 to 2007, of Corning Incorporated from 2010 to 2012, and of United Continental Holdings, Inc. from 2010 to 2012.
Age: 67  Director Since 2013      
847 932-7900

Glenn Tilton Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 9.64 % which means that it generated profit of $9.64 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 101.06 % meaning that it created $101.06 on every $100 dollars invested by stockholders.
The company currently holds 38.09 B in liabilities with Debt to Equity (D/E) ratio of 569.6 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AbbVie Inc has Current Ratio of 1.42 which is within standard range for the sector.

Similar Executives

Showing few of many executives


David AltshulerVertex Pharmaceuticals Incorpor
Patrick OSullivanAllergan plc
William MontagueEndo International plc
Sharad MansukaniEndo International plc
Fred WeissAllergan plc
Christopher BodineAllergan plc
William YoungVertex Pharmaceuticals Incorpor
Elaine UllianVertex Pharmaceuticals Incorpor
Peter McDonnellAllergan plc
Nesli BasgozAllergan plc
Alan GarberVertex Pharmaceuticals Incorpor
William OsbornAbbott Laboratories
Michael HyattEndo International plc
Robert MalchioneBio Rad Laboratories Inc
Terrence KearneyVertex Pharmaceuticals Incorpor
David GreenwayVertex Pharmaceuticals Incorpor
James BloemAllergan plc
Douglas IngramEndo International plc
Yuchun LeeVertex Pharmaceuticals Incorpor
Arthur HigginsEndo International plc
W FarrellAbbott Laboratories

Entity Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical solutions worldwide. AbbVie Inc (ABBV) is traded on New York Stock Exchange in USA. It is located in ILLINOIS, U.S.A and employs 28,000 people. AbbVie is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Portfolio Quick Import Now

Portfolio Quick Import

Import or update all your transactions via one easy-to-use interface
Hide  View All  NextLaunch Portfolio Quick Import
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add AbbVie Inc to your portfolio

Top Management

AbbVie Inc Leadership Team
Richard Gonzalez, Chairman
Thomas Hurwich, President
Frederick Waddell, Director
Robert Alpern, Director
Glenn Tilton, Director
Carlos Alban, EVP
Robert Michael, President
Henry Gosebruch, President
Edward Liddy, Director
Brett Hart, Director
William Chase, CFO
William Burnside, Director
Roxanne Austin, Director
Timothy Richmond, SVP
Laura Schumacher, EVP
Roy Roberts, Director
Michael Severino, President
Azita SalekiGerhardt, President, Ph.D
Edward Rapp, Director

Stock Performance

AbbVie Performance Indicators